Skip to Main Content

Biotech once looked to China for cheap labor. It may soon find mounting competition instead.

Thanks to bountiful investments and loosening regulations, China has become a nascent biotech powerhouse that investors and entrepreneurs say could one day rival the industry’s Western incumbents. Fueled by a sudden influx of foreign-trained talent, a new generation of Chinese startups is racing to treat the world with medicines invented at home.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

Comments are closed.